0
    Nova
    Body + BrainBody & Brain

    "Perceptronium," Cyber Citizen Science, and RNAi: NOVA Next Week in Review

    ByAllison EckNOVA NextNOVA Next

    This Week’s NOVA Next Feature Article

    TTR amyloidosis is debilitating and, even with today’s medicine, ultimately fatal. But there’s hope with a new therapy called RNAi. NOVA Next contributor Cassandra Willyard reports that if it works, it could cure TTR amyloidosis and open new doors for the treatment of other diseases.

    In a lab in Cambridge, Massachusetts, researchers are racing to develop a cure for TTR amyloidosis.

    In other news from NOVA and around the web:

    Did you miss "Inside Animal Minds: Who’s the Smartest?" Stream it here—and remember, it will only be available for the next four weeks.

    Photo courtesy Alnylam

    Funding for NOVA Next is provided in part by the Eleanor and Howard Morgan Family Foundation.

    Major funding for NOVA is provided by the NOVA Science Trust, the Corporation for Public Broadcasting, and PBS viewers.